![]() Fulcrum Therapeutics We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are. | ![]() Genevant Genevant offers a lipid nanoparticle (LNP) platform that enables clinical development of RNA-based therapeutics. | ||
Founding Date | Founding Date 2010 | Founding Date 2016 | Founding Date 2017 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Ecublens, CH HQ Cambridge, US | Locations Cambridge, US HQ | Locations New York, US HQ |
Employees | Employees 219% decrease | Employees 43223% increase | Employees 524% decrease |
Funding | |||
Total funding raised | Total funding raised $ 77.6m | Total funding raised $ 55m | Total funding raised N/A |

We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are.
View company
Genevant offers a lipid nanoparticle (LNP) platform that enables clinical development of RNA-based therapeutics.
View company